By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Zura Bio Limited

Zura Bio Limited (ZURA)

NASDAQ Currency in USD
$222.00
+$1.86
+0.85%
Last Update: 18 Jul 2026, 20:53
$20.90bn
Market Cap
-203.67
P/E Ratio (TTM)
Forward Dividend Yield
$159.11-$272.75
52 Week Range

ZURA Stock Price Chart

Explore Zura Bio Limited interactive price chart. Choose custom timeframes to analyze ZURA price movements and trends.

ZURA Company Profile

Discover essential business fundamentals and corporate details for Zura Bio Limited (ZURA) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

21 Mar 2023

Employees

30.00

CEO

Sandeep C. Kulkarni

Description

Zura Bio Limited is a clinical-stage biotechnology company headquartered in San Diego, California, dedicated to pioneering new therapeutic solutions for immune system and inflammatory diseases. Its key product candidates include ZB-168, an anti-IL7Rα inhibitor engineered to address conditions influenced by the IL7 and TSLP biological pathways. The company is also advancing Torudokimab, a monoclonal antibody that neutralizes IL-33, which is currently in Phase 2 clinical development.

ZURA Financial Timeline

Browse a chronological timeline of Zura Bio Limited corporate events including earnings releases, dividend announcements, and stock splits.

Upcoming earnings on 13 Aug 2026

EPS estimate is -$0.20.

Earnings released on 7 May 2026

EPS came in at -$0.22 falling short of the estimated -$0.17 by -29.41%.

Earnings released on 19 Mar 2026

EPS came in at -$0.49 falling short of the estimated -$0.18 by -172.22%.

Earnings released on 13 Nov 2025

EPS came in at -$0.21 falling short of the estimated -$0.19 by -10.53%.

Earnings released on 14 Aug 2025

EPS came in at -$0.17 surpassing the estimated -$0.19 by +10.53%.

Earnings released on 8 May 2025

EPS came in at -$0.19 falling short of the estimated -$0.17 by -11.76%.

Earnings released on 25 Mar 2025

EPS came in at -$0.08 surpassing the estimated -$0.16 by +50.00%, while revenue for the quarter reached $2.00k .

Earnings released on 7 Nov 2024

EPS came in at -$0.26 falling short of the estimated -$0.14 by -85.71%.

Earnings released on 13 Aug 2024

EPS came in at -$0.17 falling short of the estimated -$0.13 by -30.77%.

Earnings released on 9 May 2024

EPS came in at -$0.02 surpassing the estimated -$0.23 by +91.30%.

Earnings released on 26 Mar 2024

EPS came in at -$0.19 surpassing the estimated -$0.23 by +17.39%.

Earnings released on 13 Nov 2023

EPS came in at -$0.18 surpassing the estimated -$0.25 by +28.00%.

Earnings released on 14 Aug 2023

EPS came in at -$1.31 falling short of the estimated -$0.25 by -424.00%.

Earnings released on 12 May 2023

EPS came in at -$2.76 matching the estimated -$2.76.

Earnings released on 31 Mar 2023

EPS came in at -$0.27 .

Earnings released on 30 Sept 2022

EPS came in at -$0.06 .

Earnings released on 30 Jun 2022

EPS came in at -$0.05 .

Earnings released on 30 Mar 2022

EPS came in at $0.01 .

Earnings released on 30 Dec 2021

EPS came in at $0.05 .

Earnings released on 29 Sept 2021

EPS came in at $0.34 .

ZURA Stock Performance

Access detailed ZURA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run